FDA Inspection 1079969 — Aspire Fertility - Atlanta
The FDA completed an inspection of Aspire Fertility - Atlanta on Feb 8, 2019 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Atlanta, GA (United States)